FDA's Makary on Trump EO to Ease Access to Psychedelics

FDA Commissioner Michael Makary commented on President Trump's executive order aimed at increasing access to psychedelics. The EO seeks to streamline regulatory pathways for psychedelic therapies, potentially accelerating their availability for medical use.